Effective MSL Teams Leverage Field Liaisons’ Relationships and Skills to Update Thought Leader Databases

MSLs are uniquely positioned to continually update a company’s thought leader database to capture emerging thought leaders and fluctuating levels of influence among KOLs.

Effective MSL Teams Leverage Field Liaisons’ Relationships and Skills to Update Thought Leader Databases

<0> Cutting Edge InformationElio Evangelista, 919-403-6583 </0>

Top-performing leverage their MSLs’ positions in the medical community to continuously update thought leader databases, according to a new study by Cutting Edge Information.

Today’s MSLs contribute to a range of activities at pharmaceutical and medical device companies. However, an MSL’s key role remains interacting with (KOLs) and physicians. To optimize their relationships and their impact on product performance, MSLs must be careful to work with the best thought leaders for the job.

Cutting Edge Information’s recent study, “MSL Activities and Performance Measurement: Harnessing KOL Relationships for Optimal Clinical Support,” suggests that MSLs actively cycle out retired or less-influential KOLs and replace them with up-and-coming talent.

“Life sciences companies need to stay ahead of thought leaders’ evolving influence levels and gain a foothold with emerging KOLs,” said Elio Evangelista, director of operations at Cutting Edge Information. “Everyday, physicians retire, move or decide to focus on more specialized areas. Simultaneously, new doctors emerge from medical school every year and begin to mold themselves into local, regional, or even national thought leaders.”

MSLs’ never-ending work on thought leader databases can be demonstrated by the percentage of new KOL relationships begun each year. CEI’s study found a high average percentage of KOL relationships less than one year old across all company types. Averages ranged from 39% at large Top 20 companies to 74% of relationships less than one year old at small and biotech companies.

“MSL Activities and Performance Measurement: Harnessing KOL Relationships for Optimal Clinical Support” () explores the best practices and benchmarks for top-performing MSL teams at companies in the US, Europe, Canada and Asia Pacific. This report is designed to help medical affairs departments and MSL teams:

For more information about medical science liaisons and , contact Elio Evangelista at 919-403-6583.

Suggested Articles

Passage Bio filed to raise $125 million in its IPO. Now, it has outraised that goal by $91 million with a $216 million Wall Street debut.

The ruling reflects the judge’s belief that the FDA’s interpretation of the law on clinical trial reporting “is unlawful and must be set aside.”

Trutino will apply a platform designed to yield safer, more effective cytokines to the discovery of three oncology drugs for Boehringer.